Package 0078-0393-61

Brand: simulect

Generic: basiliximab
NDC Package

Package Facts

Identity

Package NDC 0078-0393-61
Digits Only 0078039361
Product NDC 0078-0393
Product ID 0078-0393_3a12b631-15b1-4b4a-a018-692037cc4709
Description

1 VIAL, SINGLE-USE in 1 CARTON (0078-0393-61) / 2.5 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 1998-05-12
Brand simulect
Generic basiliximab
Sample Package No

Linked Drug Pages (1)

Simulect ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3a12b631-15b1-4b4a-a018-692037cc4709", "openfda": {"nui": ["N0000010279", "N0000175621", "N0000175622"], "unii": ["9927MT646M"], "rxcui": ["1656643", "1656646", "1656648", "1656650"], "spl_set_id": ["1af01887-b69d-444b-91ed-ebfe12784440"], "pharm_class_epc": ["Interleukin-2 Receptor Blocking Antibody [EPC]"], "pharm_class_moa": ["Interleukin 2 Receptor Antagonists [MoA]", "Interleukin 2 Receptor-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0078-0393-61)  / 2.5 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0078-0393-61", "marketing_start_date": "19980512"}], "brand_name": "Simulect", "product_id": "0078-0393_3a12b631-15b1-4b4a-a018-692037cc4709", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Interleukin 2 Receptor Antagonists [MoA]", "Interleukin 2 Receptor-directed Antibody Interactions [MoA]", "Interleukin-2 Receptor Blocking Antibody [EPC]"], "product_ndc": "0078-0393", "generic_name": "basiliximab", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Simulect", "active_ingredients": [{"name": "BASILIXIMAB", "strength": "10 mg/2.5mL"}], "application_number": "BLA103764", "marketing_category": "BLA", "marketing_start_date": "19980512", "listing_expiration_date": "20261231"}